Back to Search
Start Over
C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3
- Source :
- Hepatology International. 13:277-292
- Publication Year :
- 2019
- Publisher :
- Springer Science and Business Media LLC, 2019.
-
Abstract
- The aim of our study was to explore how C1QTNF1-AS1 regulated miR-221-3p/SOCS3 axis in human hepatocellular carcinoma (HCC). Differentially expressed lncRNAs and genes were examined via RNA-seq. GO analysis and KEGG pathway enrichment analysis were carried out based on the function of dys-regulated mRNAs. RT-qPCR was employed to detect the relative mRNA expression level of C1QTNF1-AS1, miR-221-3p, SOCS3 and key genes in the JAK/STAT signaling pathway in HCC tissues and cells, and western blot analysis was conducted to detect the relative protein expression levels of SOCS3 and key proteins in the JAK/STAT signaling pathway in HCC tissues and cells. MTT assay, transwell assay and flow cytometry were utilized to assess HCC cell proliferation, invasion, migration and apoptosis. Dual luciferase reporter gene assay was used to verify the targeted relationship between C1QTNF1-AS1 and miR-221-3p, as well as between miR-221-3p and SOCS3. A tumorigenicity assay in nude mice was conducted to investigate the effects of C1QTNF1-AS1 on HCC tumor growth in vivo. C1QTNF1-AS1 and SOCS3 were down-regulated, while miR-221-3p was up-regulated in HCC tissues and cells. In HepG2 and Huh7 cells, overexpression of C1QTNF1-AS1 or SOCS3, as well as silence of miR-221-3p inhibited HCC cell proliferation, migration, and invasion and promoted HCC cell apoptosis. The results of the dual luciferase reporter gene assay indicated that miR-221-3p could directly target both C1QTNF1-AS1 and SOCS3. In addition, up-regulation of C1QTNF1-AS1 suppressed HCC tumor growth in vivo. Overexpression of C1QTNF1-AS1 down-regulated miR-221-3p and subsequently up-regulated SOCS3, thereby inhibiting HCC cell proliferation, migration and invasion and promoting apoptosis through the JAK/STAT signaling pathway.
- Subjects :
- Oncology
medicine.medical_specialty
Carcinoma, Hepatocellular
MEDLINE
Mice, Nude
Flow cytometry
Mice
03 medical and health sciences
0302 clinical medicine
Western blot
In vivo
Internal medicine
Cell Line, Tumor
Animals
Humans
Medicine
MTT assay
SOCS3
Hepatology
medicine.diagnostic_test
business.industry
Cell growth
Liver Neoplasms
Proteins
medicine.disease
Colorectal surgery
digestive system diseases
Gene Expression Regulation, Neoplastic
MicroRNAs
Suppressor of Cytokine Signaling 3 Protein
Apoptosis
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Cancer research
RNA, Long Noncoding
030211 gastroenterology & hepatology
business
Subjects
Details
- ISSN :
- 19360541 and 19360533
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Hepatology International
- Accession number :
- edsair.doi.dedup.....61cc2c8349db4f23ea988b7305cfbf84